Delivery Order SPE2DB24D3013-SPE2DB25FFGPH

Award Date 11/18/24
Potential Completion Date 11/19/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,039.56, is for the delivery of 90 tablets of the medication VERQUVO 10 MG. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00, which provides a global pharmaceutical support vehicle to supply a wide range of medical products...
This is a $9,768.57 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of the medication VERQUVO 5 MG TABLET 30S, with a period of performance through June 24, 2025. This award is not set-aside and represents an individual delivery order under Amerisourcebergen's larger $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,039.56 firm fixed-price delivery order is for the supply of VERQUVO 10 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,016.04 firm fixed-price contract is for the supply of VERQUVO 2.5 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2023. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of the pharmaceutical product VERQUVO 5 MG TABLET 30S. The contract has a firm fixed price of $2,729.58 and an ultimate completion date of August 2, 2024. No set-aside designation was used for this award. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this delivery order, which is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,532.49 delivery order contract is for the supply of the prescription medication VERQUVO 10 MG TABLET 30S. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. This award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,979.59, is for the delivery of the prescription medication VERQUVO 2.5 MG TABLET 30S. It is a firm fixed-price contract with an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.41 firm fixed-price delivery order contract is for the supply of 4567612693 ! VERQUVO 10 MG TABLET 30S, a pharmaceutical product. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,705.63, is for the delivery of the drug VERQUVO 10 MG TABLET 90S. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 28, 2024. The contract was awarded on October 25, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a for-profit organization,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of VERQUVO 10 MG TABLET 30S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $3,161.72 and a performance period through October 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFGPH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug VERQUVO 10 MG TABLET 30S. The firm-fixed-price contract, valued at $4,396.10, has an ultimate completion date of November 19, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a mechanism for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside was used for this particular contract award.

Generated 5/20/25, 1:51 PM